Higuchi John W. 4

What Happened John W. Higuchi, a director of Lipocine Inc. (LPCN), made an open-market purchase of 40,000 common shares on April 7, 2026. The shares were acquired at $2.03 per share for a total transaction value of approximately $81,200. This was a purchase (code P), which investors often view as a more informative signal than routine sales, though motivations are not disclosed.

Key Details

• Transaction date: 2026-04-07
• Transaction type and code: Open-market purchase (P)
• Shares purchased: 40,000 at $2.03 per share
• Total value: $81,200
• Shares owned after transaction: Not specified in the provided filing excerpt
• Filing date / timeliness: Report filed 2026-04-07 (same day as transaction) — appears timely
• No footnotes, 10b5-1 plan, tax withholding, or other special conditions were reported in the provided data

Context

• Purchases by directors can signal confidence but do not prove future performance; they are one data point among many.
• This filing shows a straightforward open-market buy by a director (not an option exercise, award, or gift).